Leaky Gut Symptoms and Chronic Pain: The Gates Your Week Opens

Search for leaky gut symptoms and you get a long list of complaints that almost everyone in chronic pain already carries. That is exactly why the list diagnoses nothing. A symptom tells you something is wrong. It does not tell you the gut wall is the reason.

The research offers something shorter and more useful: a set of ordinary exposures that measurably open the human gut wall, and a set of consequences, from fever to falling insulin sensitivity to slipping attention, that follow when bacterial fragments get through. The video above is Chapter 4 of The Angry Gut, by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. For a pain patient, the part that matters most is not the anatomy of the wall. It is how many of the things you do to survive a painful week are the same things that open it.

Leaky gut symptoms are not a checklist

The gut lining is one cell thick, the outer surface of the first brain. Its seal lives in the claudins, the proteins that keep the gaps between cells closed. When that seal loosens, what you feel depends on what crosses and on the immune cells waiting behind it.

Some reactions can be filmed. Using a confocal laser endomicroscope, physicians dripped food antigens onto the lining of people with irritable bowel syndrome. Seventy-six of 108 reacted within minutes, most often to wheat, and the reactors showed upregulated claudin-2 on biopsy (Fritscher-Ravens et al., 2019). The reactors also carried more immune cells inside the lining, P = .001. Forty-seven of the 155 people enrolled never finished the protocol, so the true share is uncertain.

Now the counterexample. Nineteen women with constipation-predominant irritable bowel syndrome were compared with 18 healthy women using five separate methods, from tissue resistance in a chamber to sugar recovery in urine. Every method found a normal wall (Peters et al., 2017). The one abnormality was in secretion, not structure. Same diagnostic label, and the wall was intact.

The painkiller on the counter

In healthy volunteers, a single dose of an anti-inflammatory drug more than doubled small-bowel permeability, from 0.030 to 0.071 on the sugar test (Vanuytsel et al., 2014). One dose, in people with no pain and no gut disease.

Translate that into a pain practice. Many people who reach us have taken an anti-inflammatory most days for years, for a pain whose source nobody traced. It is a good drug. After an injury, for a week, it does exactly its job. As a permanent floor under an unexplained pain, it holds a gate open that nobody is watching. In people living with type 2 diabetes the cardiac side is its own problem, covered in our review of NSAIDs and heart failure risk.

The habit has an economic engine. A bottle on a pharmacy shelf costs less time than a workup, and a system paid per visit rewards the refill over the question of why the pain is still there. None of this is a reason to stop a medication on your own. It is a reason to put the daily dose on the table with your physician and ask what the plan is for the cause.

Stress, and a finding that did not hold

Stress belongs on the list, and the evidence is messier than most accounts admit. In the original experiment, giving a public speech raised small-bowel permeability to 0.059. An infusion of corticotropin-releasing hormone, the chemical that starts the stress response, reproduced the effect, and a mast cell stabilizer blocked it (Vanuytsel et al., 2014).

I repeated that mast cell mechanism for years as if it were settled. It is not. The same laboratory ran a double-blind rematch in 20 healthy volunteers, gave 100 micrograms of the hormone into a vein, and measured duodenal biopsies directly. Permeability did not change, and mast cell counts did not move. Applied straight to the tissue in a chamber, the hormone did lower barrier resistance, P = 0.010, and a mast cell blocker failed to stop it (Schol et al., 2025).

The fair summary is that stress chemistry can open the wall under some conditions, and the mast cell explanation is no longer secure. For someone in chronic pain, that makes stress a physiological input to treat, not a character flaw.

What crosses the wall reaches a body already in pain

Endotoxin is a fragment of the outer coat of certain gut bacteria, and the immune system treats it as invasion. Give 3 ng/kg intravenously to healthy volunteers and the result is a short, real illness. Interleukin-6 climbed from 3.2 to 1,607 at two hours. Core temperature rose from 36.5 to 37.7 degrees C. A day later insulin sensitivity was down 35%, while the pancreas kept secreting insulin normally (Mehta et al., 2010).

Fever, an inflammatory surge and insulin resistance, in human beings, from one exposure. That dose is far larger than anything a meal delivers, and the limit matters. The direction still matches what we see: insulin resistance turns up again and again in patients whose pain will not settle, a mechanism laid out in how high insulin makes you hurt.

Everyday doses are smaller and more frequent. After one evening of vodka at 2 ml per kilogram of body weight, blood endotoxin rose in 25 healthy adults within 30 minutes, and bacterial DNA was still circulating at 24 hours. Women took up more than men from the same weight-adjusted dose (Bala et al., 2014). Food moves the same system. Eighteen healthy men overfed by 760 calories a day for eight weeks saw endotoxin after meals rise 160%, yet only four of the eight men in the meal arm mounted an inflammatory response (Laugerette et al., 2014).

That split is the insight most accounts miss. Exposure is not response. Everyone got the fragments. What differed was the terrain receiving them, which is why the same week hurts two people differently.

The second brain notices too. In 51 women who ate a high-saturated-fat meal and a high-oleic-oil meal on different days, a higher baseline level of LBP, the carrier protein for endotoxin, predicted less consistent attention after eating, and where LBP was high the better oil lost its advantage (Madison et al., 2020). Endotoxin itself was not measured, so read it as a signal rather than proof.

When the gut is not the whole answer

A leaky wall is one road in, never the only one. In healthy relatives of people with Crohn’s disease, those from families with several affected members carried the highest risk, yet their walls were no more permeable than lower-risk relatives. What set them apart was low-grade inflammation and the bacteria living against the wall (Olivera et al., 2025).

Pain works the same way. A scan, a lab or a gut test can each point at something real that is not the whole story, the trap described in why your scan does not match your pain. The signal from the gut reaches the second brain by the vagus, the tether traced in the previous chapter on the first brain and its wiring.

Closing the gates in a pain practice

Order matters. The wall gets attention early, because treatment stacked on an open gate keeps washing out. That starts with an honest inventory of the week: the daily anti-inflammatory and what it is covering, the drinks, the large fat-and-sugar meals, the heat loads, and a stress response that never switches off. Each has a measured effect in human volunteers.

Lifestyle work here is treatment, not aftercare, and each piece has a physiological reason. Smaller, whole-food meals avoid the post-meal endotoxin surge that overfeeding provokes. Managing stress chemistry removes one hormonal key to the gate. And interventional care that calms a pain generator can reduce the need for a daily anti-inflammatory, which removes the most common chemical key of all. The injection is not the treatment. It buys the window in which the gut, the metabolism and the nervous system can be retrained.

Then comes what already leaked through: the insulin resistance and the inflammation feeding sensitized nerves, covered in how metabolic inflammation sustains chronic pain. Every study above, including the rematch that failed and the strongest case against the endotoxin story, is laid out with its full numbers in the Chapter 4 Deep Dive.

Frequently asked questions

Can leaky gut cause body aches and fatigue?

It can contribute, though symptoms alone cannot prove it. When healthy volunteers received bacterial endotoxin, the fragment that crosses a loosened gut wall, they developed fever, a large inflammatory surge and reduced insulin sensitivity within a day. Those are the ingredients of feeling unwell. The same aches have many other causes, which is why a careful workup matters, as our guide to evaluating widespread pain explains.

Does ibuprofen cause leaky gut?

Anti-inflammatory drugs in that class open the gut wall measurably. In healthy volunteers, one dose more than doubled small-bowel permeability on a sugar test. Short courses for an injury are what these drugs are for. The concern is the daily dose taken for years with no plan for the cause. Do not stop or change a medication on your own; review it with your physician, and read what long-term NSAID use does to the heart in diabetes.

Can stress cause leaky gut?

Sometimes. Public speaking raised small-bowel permeability in healthy volunteers, and a stress hormone infusion reproduced the effect in the original study. A later double-blind rematch from the same laboratory found no change in duodenal permeability, so the mechanism is not settled. Chronic stress is still a physiological load worth treating, and loneliness is one of the heaviest, as social isolation as an inflammatory state describes.

Does alcohol make the gut leak?

Yes, and quickly. In healthy adults, a single evening of heavy drinking raised blood endotoxin within half an hour and left bacterial DNA in the blood the next day, with women affected more than men at the same weight-adjusted dose. For people in chronic pain, alcohol adds a second problem through its breakdown products, explained in alcohol, acetaldehyde and chronic pain.

Where does endotoxin from the gut go first?

To the liver. Blood draining the bowel travels through the portal vein to the liver before it reaches the heart or the rest of the body, so the liver filters bacterial fragments around the clock. When that filter is loaded with fat, the consequences change, and a fatty liver can form in people who never drink. That story is told in the next chapter on fatty liver and gut-made alcohol.

Sources

1. Vanuytsel, T., van Wanrooy, S., Vanheel, H., Vanormelingen, C., Verschueren, S., Houben, E., Salim Rasoel, S., Toth, J., Holvoet, L., Farre, R., Van Oudenhove, L., Boeckxstaens, G., Verbeke, K., & Tack, J. (2014). Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut, 63(8), 1293–1299. https://doi.org/10.1136/gutjnl-2013-305690
2. Schol, J., Huang, I.-H., Balsiger, L., Toth, J., Van den Houte, K., Verheyden, A., Raymenants, K., Broeders, B., Vanuytsel, T., & Tack, J. (2025). The effect of corticotropin-release hormone on duodenal permeability and immune activation in healthy volunteers in a double-blind placebo-controlled study. American Journal of Physiology. Gastrointestinal and Liver Physiology, 328(5), G457–G464. https://doi.org/10.1152/ajpgi.00130.2024
3. Mehta, N. N., McGillicuddy, F. C., Anderson, P. D., Hinkle, C. C., Shah, R., Pruscino, L., Tabita-Martinez, J., Sellers, K. F., Rickels, M. R., & Reilly, M. P. (2010). Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes, 59(1), 172–181. https://doi.org/10.2337/db09-0367
4. Bala, S., Marcos, M., Gattu, A., Catalano, D., & Szabo, G. (2014). Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PLoS One, 9(5), e96864. https://doi.org/10.1371/journal.pone.0096864
5. Laugerette, F., Alligier, M., Bastard, J.-P., Drai, J., Chanséaume, E., Lambert-Porcheron, S., Laville, M., Morio, B., Vidal, H., & Michalski, M.-C. (2014). Overfeeding increases postprandial endotoxemia in men: Inflammatory outcome may depend on LPS transporters LBP and sCD14. Molecular Nutrition & Food Research, 58(7), 1513–1518. https://doi.org/10.1002/mnfr.201400044
6. Madison, A. A., Belury, M. A., Andridge, R., Shrout, M. R., Renna, M. E., Malarkey, W. B., Bailey, M. T., & Kiecolt-Glaser, J. K. (2020). Afternoon distraction: A high-saturated-fat meal and endotoxemia impact postmeal attention in a randomized crossover trial. The American Journal of Clinical Nutrition, 111(6), 1150–1158. https://doi.org/10.1093/ajcn/nqaa085
7. Fritscher-Ravens, A., Pflaum, T., Mösinger, M., Ruchay, Z., Röcken, C., Milla, P. J., Das, M., Böttner, M., Wedel, T., & Schuppan, D. (2019). Many patients with irritable bowel syndrome have atypical food allergies not associated with immunoglobulin E. Gastroenterology, 157(1), 109–118.e5. https://doi.org/10.1053/j.gastro.2019.03.046
8. Peters, S. A., Edogawa, S., Sundt, W. J., Dyer, R. B., Dalenberg, D. A., Mazzone, A., Singh, R. J., Moses, N., Smyrk, T. C., Weber, C., Linden, D. R., MacNaughton, W. K., Turner, J. R., Camilleri, M., Katzka, D. A., Farrugia, G., & Grover, M. (2017). Constipation-predominant irritable bowel syndrome females have normal colonic barrier and secretory function. The American Journal of Gastroenterology, 112(6), 913–923. https://doi.org/10.1038/ajg.2017.48
9. Olivera, P. A., Martinez-Lozano, H., Leibovitzh, H., Xue, M., Neustaeter, A., Espin-Garcia, O., Xu, W., Madsen, K. L., Guttman, D. S., Bernstein, C. N., Yerushalmi, B., Hyams, J. S., Abreu, M. T., Marshall, J. K., Wrobel, I., Mack, D. R., Jacobson, K., Bitton, A., Aumais, G., … Croitoru, K. (2025). Healthy first-degree relatives from multiplex families vs simplex families have higher subclinical intestinal inflammation, a distinct fecal microbial signature, and harbor a higher risk of developing Crohn’s disease. Gastroenterology, 168(1), 99–110.e2. https://doi.org/10.1053/j.gastro.2024.08.031

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 4 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.

Dr. Gurpreet Singh Padda, MD, MBA, MHP